The Latest Advancements in Type 1 & Type 2 Diabetes
…Shared in a Way Everyone Can Understand.
Welcome to the 18th Annual (5th Virtual!) Diabetes Forum
At TCOYD, we believe that everyone should have access to understandable and practical diabetes information. Our Virtual Diabetes Forum features recorded expert panel discussions, explained by our leading doctors, Dr. Steve Edelman and Dr. Jeremy Pettus. They break down complex medical jargon into easy-to-understand language for people living with diabetes (just like you!). Stay up to date with the latest diabetes advancements!
WHAT YOU WILL LEARN AT DIABETES FORUM
The Virtual Diabetes Forum will discuss various important topics related to diabetes management and recent advancements in treatment.
You’ll Get Insight Into:
Understanding New Diabetes Medications – What are GLP-1 RAs, and how can they help manage not only diabetes but also obesity, heart disease, kidney disease, and other health benefits
AI and Diabetes Management – How artificial intelligence will help improve the care of people with diabetes and obesity in more efficient and effective ways.
Maintaining Muscle Mass – Why it’s important to preserve muscle mass, especially while losing weight on GLP-1 type medications
Preventing and Preserving Islet cells in people with early stages of Type 1 Diabetes – Learn the latest advancements in this exciting area of research.
Islet Cell Replacement Therapy for those already with type 1 diabetes – Is replacing islet cells a future cure for type 1 diabetes?
New Treatment Guidelines from the ADA – The latest treatment recommendations for diabetes care and how they can help you.
Hot topic of CKM (Continuous Ketone Monitoring) – Discover the potential of this emerging technology in revolutionizing diabetes management
Understanding Obesity and Diabetes – How factors beyond eating and exercising affect obesity.
Technology in Diabetes Care – How new technologies make diabetes management easier and more effective for people with T1D and T2D.
Exciting new pillars of therapy to prevent the progression of diabetic kidney diseases – What can you do as a provider and someone living with diabetes to prevent the need for dialysis or transplantation?
MEET YOUR EXPERT ENDO SPEAKERS
*extra-relatable faculty (they're living with type 1)
*STEVEN V. EDELMAN, MD
Founder & Director, TCOYD; Endocrinologist, Clinical Professor of Medicine, University of California, San Diego (UCSD) School of Medicine; Director, Diabetes Care Clinic, VA Medical Center San Diego
Dr. Edelman is a professor of medicine in the Division of Endocrinology, Diabetes & Metabolism at the University of California, San Diego (UCSD) and the Veterans Affairs (VA) Healthcare System of San Diego. Dr. Edelman, who has type 1 diabetes himself, has written more than 200 articles, five books, and has won numerous awards for teaching and humanitarianism. He has been chosen by the medical students at UCSD as the ‘teacher of the year’ numerous times. Among his many honors, Dr. Edelman has received the ‘Diabetes Educator Of The Year’ award by the American Diabetes Association, the ‘Distinction in Endocrinology’ award by the American Association of Clinical Endocrinologists, and named ‘Top 1% of U.S. Endocrinologists’ by US News and World Report.
*JEREMY PETTUS, MD
Type 1 Track & Professional Education Director, Endocrinologist, Associate Professor of Medicine, UCSD School of Medicine
Dr. Jeremy Pettus was diagnosed with type 1 diabetes when he was 15 years old. Since that time he has dedicated his career to educating and treating others like himself. He is currently an Endocrinologist and Assistant Professor of Medicine at the University of California, San Diego. There, he focuses primarily on clinical trials to develop and test new and innovative therapies for people living with diabetes. These include studies ranging from medications to reverse or slow the disease once it occurs, to islet cell transplantation strategies, to device studies such as artificial pancreas technology. As somebody who has the disease himself, sees patients with type 1, and is actively working on curing/treating the disease, we are honored to have him at TCOYD.